Amyloidosis Foundation
Supporting amyloidosis patients and families while promoting research, education and awareness
Supporting amyloidosis patients and families while promoting research, education and awareness
Don’t miss this story about the latest ATTR amyloidosis research.
Join Dr. Fredrick Ruberg and Dr. Omar Siddiqi as they discuss the general overview of ATTR treatment with new developments over the past…
A clinical research study for transthyretin amyloid cardiomyopathy (ATTR-CM). See if you may qualify for the DepleTTR-CM Study.
A clinical research study for transthyretin amyloid cardiomyopathy (ATTR-CM). See if you may qualify for the DepleTTR-CM Study.
“Light the Night for Amyloidosis” is an awareness campaign created to draw attention to amyloidosis symptoms, diagnosis, treatment, and hopefully a cure! Since ‘Amyloidosis Awareness…
Ultromics has partnership with Pfizer to expedite the development and pursue FDA clearance for its AI platform to detect cardiac amyloidosis.
Scientific Reports – Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid…
PROGRAM SCHEDULE / GUEST FACULTY: Welcome Remarks Jeffrey Zonder, MD Karmanos Cancer Institute MI Making the Diagnosis and Assigning Prognosis of AL…
Supporting amyloidosis patients and their families while promoting research, education and awareness. www.amyloidosis.org 1-877-AMYLOID info@amyloidosis.org